About Enhancer

Enhancer ID: E_02_0410
Species: human
Position : chr7:129609040-129611040
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Obesity and type 2 diabetes
Pubmed ID:  30284014
Enhancer experiment: RNA-Seq?ChIP-Seq?qPCR?TSS
Enhancer experiment description: Furthermore, in line with the epigenome in DIO mice, palmitate treatment caused increase in H3K27ac and induction of ?-oxidation genes; these responses were blunted when NRF1, GABPA or MEF2A were suppressed.

About Target gene

Target gene : NRF1
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: Furthermore, in line with the epigenome in DIO mice, palmitate treatment caused increase in H3K27ac and induction of ?-oxidation genes; these responses were blunted when NRF1, GABPA or MEF2A were suppressed.

About TF

TF name : --
TF experiment: RNA-Seq?ChIP-Seq?qPCR?TSS
TF experiment description: Furthermore, in line with the epigenome in DIO mice, palmitate treatment caused increase in H3K27ac and induction of ?-oxidation genes; these responses were blunted when NRF1, GABPA or MEF2A were suppressed.

About Function

Enhancer function : Furthermore, in line with the epigenome in DIO mice, palmitate treatment caused increase in H3K27ac and induction of ?-oxidation genes; these responses were blunted when NRF1, GABPA or MEF2A were suppressed.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
Furthermore, in line with the epigenome in DIO mice, palmitate treatment caused increase in H3K27ac and induction of ?-oxidation genes; these responses were blunted when NRF1, GABPA or MEF2A were suppressed.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs